Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Elżbieta PaszekKrzysztof P MalinowskiMichał Tomasz ZąbczykSaulius ButenasAnetta UndasPublished in: European journal of clinical investigation (2023)
To our knowledge, this study is the first to show that circulating FXIa is associated with prothrombotic fibrin clot properties in CAD, suggesting additional mechanisms through which FXIa inhibitors could act as novel antithrombotic agents in CAD.